Sialic acid content of low-density lipoprotein in hemodialysis patients

Dialysis and Transplantation

Volumn 31, Issue 2, 2002, Pages 97-105

  Serdar, Muhittin A ^a   Yilmaz, Kurtuluş ^a   Günaydin, Aybars ^a   Tapan, Serkan ^a   Çaǧlar, Kayser ^a   Yaman, Halil ^a   Özgürtaş, Taner ^a   Kutluay, Türker ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIALIC ACID; TRIACYLGLYCEROL;

ADULT; AGED; ATHEROSCLEROSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MALE; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0036158193     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Comparative mortality from cardiovascular disease in patients with chronic renal failure
2. Accelerated atherosclerosis in prolonged maintenance hemodialysis
3. Occlusive arterial disease in uraemic and hemodialysis and renal transplant recipients: A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of atherosclerosis
4. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis
5. Risk factors for accelerated atherosclerosis in renal transplant recipients
6. Hyperlipidemia in renal disease
7. Lipid and lipoprotein (a) concentrations in renal transplant patients
8. Role of net charge of low density lipoproteins in high affinity binding and uptake by cultured cell
9. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: Discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients
10. Desialylated low density lipoprotein-naturally occurring modified lipoprotein with atherogenic potency
11. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation
12. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins
13. Identification of multiple subclasses of plasma low density lipoproteins in normal humans
14. Sequential flotation ultracentrifugation
15. Protein measurement with the folin phenol reagent
16. Fluorometric assay of sialic acid in the picomole range: A modification of the thiobarbituric acid assay
17. The enzymatic methods of sialic acids
18. The pathogenesis of atherosclerosis: A perspective for the 1990's
19. Biochemistry of arterial wall in developing atherosclerosis
20. Hypertension in chronic renal disease
21. Inhibition of lipoprotein lipase by uremic plasma: A possible cause of hypertriglyceridemia
22. Lipoprotein metabolism in normal and uremic patients
23. Atherogenic lipids and lipoproteins in hemodialysis patients
24. Sialic acid in human cancer
25. Carbohydrate composition of protein and lipid components in sialic acid-rich and poor low density lipoproteins from subjects with and without coronary artery disease
26. Sialic acid and the metabolism of low density lipoprotein
27. Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions
28. Sialic acid content of LDL and lipoprotein metabolism in combined hyperlipidemia and primary moderate hypercholesterolemia
29. Similarity between naturally occurring modified desialylated electronegative and aortic low density lipoprotein
30. Evaluation of the sialic acid content of LDL as a marker of coronary calcification and extracoronary atherosclerosis in asymptomatic hypercholesterolemic subjects
31. Elevated serum and urine sialic acid levels in renal disease